Skip to main content

Walk-ins for Quality Control & Production Department Neuland Laboratories Ltd,Hyderabad

Dear Viewers of my blog , it brings me pleasure in sharing the following Walk-in for Quality Control & Production Department of Neuland Laboratories, Hyderabad. The  following are the details of the Walk-in:

Job Description

Department: Quality Control
Date: 07th May, 2016 (Saturday)
Position: Chemists / Officers / Executives
Experience: 02 Years - 06 Years
Venue: Neuland Laboratories Ltd, Survey No: 8-2-120/113, Road No:2, Sanali Info Park, Near TDP Office, Hyderabad, Telangana
Time: 09:00 AM to 03:00 PM
Contact Person: Mr Srinivasulu / Mr Tapan
Phone: 08458 392726 / 76

You are advised to carry the below set of mandatory documents on the day of interview:

1. Updated CV 2 Nos
2. Educational Certificates
3. Photograph - 2 Nos
4. Documents pertaining to your previous employment(s) - Originals along with a set of photocopies:
a) Latest 3 Pay slips
b) Latest salary revision Letter (if applicable)

If your candidature doesnt match with our current requirement, please ignore the mail and feel free to refer your friends.
We are looking forward to see on the above said dates.

NOTE: Candidates only with API / Bulk Drugs Manufacturing background & Male is preferable.


Route Map :: Kukatpally / Secunderabad -- Ameerpet (Mythrivanam)-- Jubilee Checkpost -- (Towards Punjagutta) -- Neuland Laboratories Ltd.


Salary: INR 1,00,000 - 4,50,000 P.A
Industry: Pharma / Biotech / Clinical Research
Functional Area: Production, Manufacturing, Maintenance
Role Category: Quality Assurance/Quality Control Executive

Desired Profiles:

Education: UG -Any Graduate - Any Specialization
PG - Any Postgraduate - Any Specialization
Doctorate - Doctorate Not Required

Good Luck.

Labels:

Comments

Post a Comment

Popular posts from this blog

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcure.co.in Rahul.Morgaonkar@emcure.co.in recruitment@em
1 comment
Read more

Novo Nordisk settles with 2 Florida venders of compounded (Semaglutide)Ozempic:

Novo Nordisk settles with 2 Florida venders of compounded Ozempic: Novo Nordisk has arrived at private settlements with two Florida merchants of intensified forms of the uber blockbuster semaglutide therapies Ozempic and Wegovy, the organization said on Friday. In June of last year, Novo recorded brand name encroachment claims against five dealers of knockoff renditions of the GLP-1 medications, which have seen soaring interest to battle weight reduction. Ekzotica Corp's. Restorative Laser Experts Drug Spa in Miami and Effinger Wellbeing's Nuvida Rx Weight reduction in Tallahassee are the initial two organizations to have settled their cases. As indicated by long-lasting directive orders, the dealers will quit utilizing Novo reserve and have consented to reveal for a considerable length of time that intensified variants of the medications have not gone through the security and viability norms expected by the FDA for supported drugs. "The litigants' unlawful showcasing
Post a Comment
Read more

Hypertension-An Overview

INTRODUCTION: Systemic arterial hypertension is one of the strongest known modifiable risk factors for ischaemic heart disease, stroke, renal failure and heart failure. It remains poorly treated. As an asymptomatic disorder, people are understandably reluctant to accept adverse drug effects in addition to the inconvenience of long-term treatment. In this regard, modern drugs represent an enormous improvement. PATHOPHYSIOLOGY AND SITES OF DRUG ACTION Hypertension is occasionally secondary to some distinct disease. However, most patients with persistent arterial hypertension have essential hypertension. Arterial blood pressure is determined by cardiac output, peripheral vascular resistance and large artery compliance. Peripheral vascular resistance is determined by the diameter of resistance vessels (small muscular arteries and arterioles) in the various tissues. One or more of a ‘mosaic’ of interconnected predisposing factors (including positive family history, obesity and phys
Post a Comment
Read more